About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Ep300
E1A binding protein p300
MGI:1276116
92 phenotypes from 7 alleles in 10 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Cd19tm1(cre)Cgn/Cd19+
Ep300tm2Reck/Ep300+
involves: 129/Sv * 129P2/OlaHsd * C57BL/6
abnormal adaptive immunity J:147840
abnormal B cell differentiation J:147840
abnormal humoral immune response J:147840
abnormal renal glomerulus morphology J:147840
abnormal spleen marginal zone macrophage morphology J:147840
abnormal transitional stage B cell morphology J:147840
arteritis J:147840
decreased B cell proliferation J:147840
decreased marginal zone B cell number J:147840
enlarged lymph nodes J:147840
enlarged spleen J:147840
extramedullary hematopoiesis J:147840
glomerulonephritis J:147840
increased activated T cell number J:147840
increased anti-double stranded DNA antibody level J:147840
increased B cell apoptosis J:147840
increased B cell number J:147840
increased IgG2b level J:147840
increased immunoglobulin level J:147840
increased megakaryocyte cell number J:147840
increased spleen weight J:147840
increased susceptibility to systemic lupus erythematosus J:147840
intermingled spleen red and white pulp J:147840
kidney inflammation J:147840
premature death J:147840
renal fibrosis J:147840
renal glomerular protein deposits J:147840
Cd19tm1(cre)Cgn/Cd19+
Ep300tm2Reck/Ep300+
involves: 129/Sv * 129P2/OlaHsd * FVB/N
increased susceptibility to systemic lupus erythematosus J:147840
premature death J:147840
Ep300Plt6/Ep300Plt6
involves: 129S1/Sv * C57BL/6
decreased B cell number J:140200
decreased eosinophil cell number J:140200
decreased leukocyte cell number J:140200
decreased lymphocyte cell number J:140200
postnatal lethality J:140200
thrombocytosis J:140200
Ep300tm1Dli/Ep300+
either: 129S4/SvJae or (involves: 129S4/SvJae * C57BL/6)
decreased embryo size J:47301
embryonic lethality during organogenesis, incomplete penetrance J:47301
exencephaly J:47301
open neural tube J:47301
Ep300tm1Dli/Ep300+
involves: 129S4/SvJae * C57BL/6
normal hematopoietic system phenotype J:60630
normal neoplasm J:60630
Ep300tm1Dli/Ep300tm1Dli
either: 129S4/SvJae or (involves: 129S4/SvJae * C57BL/6)
abnormal cell physiology J:47301
abnormal vitelline vasculature morphology J:47301
absent trabeculae carneae J:47301
decreased cardiac muscle contractility J:47301
decreased embryo size J:47301
decreased fibroblast proliferation J:47301
early cellular replicative senescence J:47301
embryonic growth retardation J:47301
embryonic lethality during organogenesis, incomplete penetrance J:47301
enlarged heart J:47301
incomplete embryo turning J:47301
incomplete somite formation J:47301
pericardial effusion J:47301
Ep300tm1Dli/Ep300tm1Dli
involves: 129S4/SvJae * C57BL/6
abnormal facial morphology J:47301
decreased embryo size J:47301
embryonic growth arrest J:47301
embryonic lethality during organogenesis, complete penetrance J:47301
exencephaly J:47301
kinked neural tube J:47301
microphthalmia J:47301
open neural tube J:47301
Ep300tm1Pkb/Ep300+
involves: 129P2/OlaHsd * C57BL/6
thrombocytosis J:98329
Ep300tm1Pkb/Ep300tm1Pkb
involves: 129P2/OlaHsd * C57BL/6
abnormal erythrocyte morphology J:98329
anemia J:98329
anisocytosis J:98329
decreased body size J:98329
decreased thymocyte number J:98329
increased megakaryocyte cell number J:98329
postnatal lethality, incomplete penetrance J:98329
thrombocytosis J:98329
Ep300tm1Reck/Ep300+
involves: 129P2/OlaHsd
abnormal atrioventricular septum morphology J:85949
abnormal epicardium development J:85949
abnormal heart development J:85949
abnormal heart valve morphology J:85949
abnormal intestinal epithelium morphology J:85949
abnormal lung development J:85949
abnormal muscle fiber morphology J:85950
abnormal muscle morphology J:85950
abnormal myogenesis J:85950
abnormal small intestinal villus morphology J:85949
abnormal small intestine morphology J:85949
abnormal vasculogenesis J:85949
atrial septal defect J:85949
cyanosis J:85949
decreased body size J:85949
decreased skeletal muscle fiber size J:85950
delayed heart development J:85949
edema J:85949, J:85950
embryonic lethality during organogenesis, incomplete penetrance J:85949, J:85950
hemorrhage J:85949
internal hemorrhage J:85949
lethality throughout fetal growth and development, incomplete penetrance J:85949, J:85950
myocardium hypoplasia J:85949
perimembraneous ventricular septal defect J:85949
perinatal lethality, complete penetrance J:85949, J:85950
respiratory failure J:85949
thin myocardium J:85949
thin ventricle myocardium compact layer J:85949
thin ventricular wall J:85949
ventricular septal defect J:85949
Ep300tm2Pkb/Ep300tm2Pkb
Tg(Lck-cre)548Jxm/0
involves: 129P2/OlaHsd * C57BL/6 * CBA
decreased single-positive T cell number J:105505
decreased thymocyte number J:105505
increased double-positive T cell number J:105505
small thymus J:105505
Ep300tm2Pkb/Ep300tm2Pkb
Tg(MMTV-cre)4Mam/0
involves: 129P2/OlaHsd * FVB
normal neoplasm J:105505
Ep300tm3Pkb/Ep300tm3Pkb
involves: 129S6/SvEvTac * C57BL/6
postnatal lethality, incomplete penetrance J:103607

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/29/2024
MGI 6.24
The Jackson Laboratory